US Patent Issued to 60 DEGREES PHARMACEUTICALS on Aug. 12 for "Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine" (District Of Columbia Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,546, issued on Aug. 12, was assigned to 60 DEGREES PHARMACEUTICALS LLC (Washington).

"Methods for the treatment and prevention of lung infections caused by fungus by administration of tafenoquine" was invented by Geoffrey S. Dow (Washington).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and composition for treating or preventing a lung infection, or related symptoms, caused by a fungus using an effective amount of tafenoquine are disclosed. Methods for treating or preventing fungal lung infections, or related symptoms, include administering an effective amount of tafenoquine are disclosed. Kits including tafenoquine and means for testing for...